- 1) Carrow, D. J., β-1,3-Glucan as a primary immune activator. Townsend Lett., 8, 86–91 (1996).
- 2) Brown, G. D., and Gordon, S., Fungal β-glucans and mammalian immunity. Immunity, 19, 311–315 (2003).
- 3) Nakagawa, Y., Ohno, N., and Murai, T., Supression by candida albicans β-glucan of cytokine release from activated human monocytes and from T cells in the presence of monocytes. J. Infect. Dis., 187, 710–713 (2003).
- 4) Nameda, S., Saito, M., Miura, N. N., Adachi, Y., and Ohno, N., Effect of nitric oxide on beta-glucan/indomethacin-induced septic shock. Biol. Pharm. Bull., 28, 1254–1258 (2005).
- 5) Hashimoto, T., Ohno, N., Adachi, Y., and Yadomae, T., Enhanced production of inducible nitric oxide synthase by β-glucans in mice. FEMS Immunol. Med. Microbiol., 19, 131–135 (1997).
- 6) Wei, D., Williams, D., and Browder, W., Activation of AP-1 and SP1 correlates with wound growth factor gene expression in glucan-treated human fibroblasts. Int. Immunopharmacol., 2, 1163–1172 (2002).
- 7) Delatte, S. J., Evans, J., Hebra, A., Adamson, W., Othersen, H. B., and Tagge, E. P., Effectiveness of beta-glucan collagen for treatment of partial-thickness burns in children. J. Pediatr. Surg., 36, 113–118 (2001).
- 8) Diluzio, N. R., and Williams, D. L., Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect. Immun., 20, 804–810 (1978).
- 9) Gonzalez-Scarano, F., and Baltuch, G., Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci., 22, 219–240 (1999).
- 10) Nakajima, K., and Kohsaka, S., Microglia: activation and their significance in the central nervous system. J. Biochem. (Tokyo), 130, 169–175 (2001).
- 11) Czlonkowska, A., Kurkowska-Jastrzebska, I., Czlonkowski, A., Peter, D., and Stefano, G. B., Immune processes in the pathogenesis of Parkinson’s disease: a potential role for microglia and nitric oxide. Med. Sci. Monit., 8, RA165–177 (2002).
- 12) Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., and Feuerstein, G. Z., Tumor necrosis factor-alpha: a mediator of focal ischemic brain injury. Stroke, 28, 1233–1244 (1997).
- 13) Kuprash, D. V., Udalova, I. A., Turetskaya, R. L., Rice, N. R., and Nedospasov, S. A., Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene, 11, 97–106 (1995).
- 14) Czop, J. K., and Austen, K. F., Properties of glycans that activate the human alternate complement pathway and interact with human monocytes beta glucan receptors. J. Immunol., 135, 3388–3393 (1985).
- 15) Thornton, B. P., Vetvicka, V., Pitman, M., Goldman, R. C., and Ross, G. D., β-Glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol., 156, 1235–1246 (1996).
- 16) Kidd, P. M., The use of mushroom glucans and proteoglycans in cancer treatment. Altern. Med. Rev., 5, 4–27 (2000).
- 17) Kataoka, K., Muta, T., Yamazaki, S., and Takeshige, K., Activation of macrophages by linear (1→3)-B-D-glucans: implications for the recognition of fungi by innate immunity. J. Biol. Chem., 277, 36825–36831 (2002).
- 18) Czop, J. K., and Kay, J., Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes. J. Exp. Med., 173, 1511–1520 (1991).
- 19) Sener, G., Toklu, H., Ercan, F., and Erkanli, G., Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int. Immunopharmacol., 5, 1387–1396 (2005).
- 20) Brennan, F. M., Maini, R. N., and Feldmann, M., Cytokine expression in chronic inflammatory disease. Br. Med. Bull., 51, 368–384 (1995).
- 21) Siebenlist, U., Franzoso, G., and Brown, K., Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol., 10, 405–455 (1994).
- 22) Read, M. A., Whitley, M. Z., Williams, A. J., and Collins, T., NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J. Exp. Med., 179, 503–512 (1994).
- 23) Williams, D. L., Ha, T., Li, C., Kalbfleisch, J. H., Laffan, J. J., and Ferguson, D. A., Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1-3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery, 126, 54–65 (1999).
Full access
The Suppressive Effect of β-Glucan on the Production of Tumor Necrosis Factor-Alpha in BV2 Microglial Cells
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.